Cargando…
Genetic Ablation of cGMP-Dependent Protein Kinase Type I Causes Liver Inflammation and Fasting Hyperglycemia
OBJECTIVE: The nitric oxide/cGMP/cGMP-dependent protein kinase type I (cGKI) signaling pathway regulates cell functions that play a pivotal role in the pathogenesis of type 2 diabetes. However, the impact of a dysfunction of this pathway for glucose metabolism in vivo is unknown. RESEARCH DESIGN AND...
Autores principales: | Lutz, Stefan Z., Hennige, Anita M., Feil, Susanne, Peter, Andreas, Gerling, Andrea, Machann, Jürgen, Kröber, Stefan M., Rath, Michaela, Schürmann, Annette, Weigert, Cora, Häring, Hans-Ulrich, Feil, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292332/ https://www.ncbi.nlm.nih.gov/pubmed/21464444 http://dx.doi.org/10.2337/db10-0760 |
Ejemplares similares
-
The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009) -
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
por: Russo, Isabella, et al.
Publicado: (2012) -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013) -
cGMP Signaling and Vascular Smooth Muscle Cell Plasticity
por: Lehners, Moritz, et al.
Publicado: (2018) -
Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)